Doctors say that GLP-1 medications can prevent lifelong obesity and Type 2 diabetes in children—but there are some worries

Doctors are looking for better options given the growing awareness of the serious health risks tied…

More drug companies are taking their clinical trials to China and Australia. U.S. officials are making moves to keep them at home.

FDA and NIH officials unveiled a package of regulatory tweaks as more companies go elsewhere for…

Explosion at Qatar Natural-Gas Plant Leaves 13 Dead, Dozens Injured

The blast struck during the startup of operations at the Ras Laffan industrial complex, as Qatar…

U.K. Prime Minister Keir Starmer Quits After Party Rebellion

Britain is headed for its sixth prime minister in seven years, an unprecedented period of political…

Can You Pass the Test That Strikes Fear Into China’s High-Schoolers?

Try a selection of questions from the notoriously difficult “Gaokao” university entrance exam.

What It Takes to Bring a Ukrainian Home From Russian Captivity

Watch to see what life looks like after a prisoner swap, one of the few areas…

U.S. Allows Iran to Sell Oil in Dollars for First Time in Decades

The decision temporarily dismantles sanctions imposed on Tehran’s oil industry, making it easier for the regime…

easyJet Board Rejects Castlelake’s $6.3 Billion Takeover Offer

The U.S. investment firm urged shareholders to consider the offer as it seeks to take the…

Building-Materials Supplier CRH to Buy Rival Arcosa for $8.5 Billion

Building-materials supplier CRH said it will acquire rival Arcosa in a deal valued at roughly $8.5…

AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion

The cash deal will add an experimental drug for moderate to severe atopic dermatitis, building up…